![Carlos Alberto Garrido Arribas](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carlos Alberto Garrido Arribas
Directeur/Membre du Conseil chez Palobiofarma SL
Profil
Carlos Alberto Garrido Arribas is the founder of FIT Inversión en Talento y Emprendimiento SGEIC SA, which was founded in 2011.
He held the title of Chairman from 2011 to 2017.
Currently, he is a Director at Palobiofarma SL.
In the past, he worked as a Director at AzureBio SL.
Postes actifs de Carlos Alberto Garrido Arribas
Sociétés | Poste | Début |
---|---|---|
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | Directeur/Membre du Conseil | - |
Anciens postes connus de Carlos Alberto Garrido Arribas
Sociétés | Poste | Fin |
---|---|---|
FIT Inversión en Talento y Emprendimiento SGEIC SA
![]() FIT Inversión en Talento y Emprendimiento SGEIC SA Investment ManagersFinance FIT Inversión en Talento y Emprendimiento SGEIC SA (Fitalent) is the venture capital subsidiary of information technology and outsourcing firm Everis Spain SL. Established in 2011, the firm is based in Madrid and manages the Fitalent Fund, investing in early-stage technology companies aiming to transform them into profitable, market-leading businesses. Fitalent's reference investor and partner, everis, provides assistance with strategic and business issues, legal and administrative advice, technological expertise, commercial activity, marketing, access to business contacts and simplifying international expansion. | Fondateur | 27/03/2017 |
AzureBio SL
![]() AzureBio SL BiotechnologyHealth Technology AzureBio SL develops and manufactures drug delivery systems. Its Sil-Oss synthetic bone regeneration system, used in dental surgery, promotes osteogenesis and angiogenesis while acting as a temporary osteoconductive scaffold prior to resorption. The firm also provides custom drug formulation and stabilization services, as well as intellectual property consulting and clinical testing. The company was founded by Arcadio Garcia de Castro in 2007 and is headquartered in Tres Cantos, Spain. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Palobiofarma SL
![]() Palobiofarma SL Pharmaceuticals: MajorHealth Technology Palo Biofarma SL discovers and develops pharmaceutical products. Its pipeline consists of receptors which target pulmonary diseases, attention-deficit disorders, glaucoma, and degenerative conditions. The company was founded by Juan Camacho Gamez in 2006 and is headquartered in Noáin, Spain. | Health Technology |
FIT Inversión en Talento y Emprendimiento SGEIC SA
![]() FIT Inversión en Talento y Emprendimiento SGEIC SA Investment ManagersFinance FIT Inversión en Talento y Emprendimiento SGEIC SA (Fitalent) is the venture capital subsidiary of information technology and outsourcing firm Everis Spain SL. Established in 2011, the firm is based in Madrid and manages the Fitalent Fund, investing in early-stage technology companies aiming to transform them into profitable, market-leading businesses. Fitalent's reference investor and partner, everis, provides assistance with strategic and business issues, legal and administrative advice, technological expertise, commercial activity, marketing, access to business contacts and simplifying international expansion. | Finance |
AzureBio SL
![]() AzureBio SL BiotechnologyHealth Technology AzureBio SL develops and manufactures drug delivery systems. Its Sil-Oss synthetic bone regeneration system, used in dental surgery, promotes osteogenesis and angiogenesis while acting as a temporary osteoconductive scaffold prior to resorption. The firm also provides custom drug formulation and stabilization services, as well as intellectual property consulting and clinical testing. The company was founded by Arcadio Garcia de Castro in 2007 and is headquartered in Tres Cantos, Spain. | Health Technology |